Current algorithm for the surgical treatment of facial pain by Slavin, Konstantin V et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Head & Face Medicine
Open Access Methodology
Current algorithm for the surgical treatment of facial pain
Konstantin V Slavin*, Hrachya Nersesyan, Mustafa E Colpan and 
Naureen Munawar
Address: Section of Stereotactic and Functional Neurosurgery, Department of Neurosurgery, University of Illinois Medical Center at Chicago, 
Chicago, Illinois, USA
Email: Konstantin V Slavin* - kslavin@uic.edu; Hrachya Nersesyan - nerses@uic.edu; Mustafa E Colpan - mcolpan@neur.uic.edu; 
Naureen Munawar - naurm@yahoo.com
* Corresponding author    
Background: Facial pain may be divided into several distinct categories, each requiring a specific
treatment approach. In some cases, however, such categorization is difficult and treatment is
ineffective. We reviewed our extensive clinical experience and designed an algorithmic approach
to the treatment of medically intractable facial pain that can be treated through surgical
intervention.
Methods:  Our treatment algorithm is based on taking into account underlying pathological
processes, the anatomical distribution of pain, pain characteristics, the patient's age and medical
condition, associated medical problems, the history of previous surgical interventions, and, in some
cases, the results of psychological evaluation. The treatment modalities involved in this algorithm
include diagnostic blocks, peripheral denervation procedures, craniotomy for microvascular
decompression of cranial nerves, percutaneous rhizotomies using radiofrequency ablation, glycerol
injection, balloon compression, peripheral nerve stimulation procedures, stereotactic radiosurgery,
percutaneous trigeminal tractotomy, and motor cortex stimulation. We recommend that some
patients not receive surgery at all, but rather be referred for other medical or psychological
treatment.
Results: Our algorithmic approach was used in more than 100 consecutive patients with medically
intractable facial pain. Clinical evaluations and diagnostic workups were followed in each case by
the systematic choice of the appropriate intervention. The algorithm has proved easy to follow, and
the recommendations include the identification of the optimal surgery for each patient with other
options reserved for failures or recurrences. Our overall success rate in eliminating facial pain
presently reaches 96%, which is higher than that observed in most clinical series reported to date
Conclusion: This treatment algorithm for the intractable facial pain appears to be effective for
patients with a wide variety of painful conditions and may be recommended for use in other
institutions.
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Background
The term "facial pain" encompasses variety of clinical con-
ditions ranging from very common (such as headaches
and myofascial pain syndromes) to less common (trigem-
inal neuralgia – TN) and quite rare (glossopharyngeal
neuralgia – GPN) (Table 1). Although clinical presenta-
tion of some of these conditions overlaps, the treatment
approaches differ significantly based on etiology, nature
and severity of pain, as well as its distribution, neurologi-
cal and psychological variables, and medical co-morbidi-
ties [1]. The diagnostic uncertainty was discussed in
multiple publications previously and remains problem-
atic [2-4] (Table 2).
As to the available procedures for treatment of the medi-
cally intractable facial pain, the spectrum of interventions
includes a wide variety of procedures starting from non-
destructive approaches (such as microvascular decom-
pression (MVD) of trigeminal and other cranial nerves) to
percutaneous interventions (radiofrequency (RF) gangli-
olysis, glycerol injection, balloon compression) to less
invasive destructive procedures (stereotactic radiosurgery)
and to neuromodulation surgeries (peripheral and central
neurostimulation) as well as central destructive surgeries
(tractotomy, etc.) (Table 3.)
Recently, two in-depth clinical articles presented different
modalities used in treatment of facial pain [5,6]. One of
them reviewed a single-institution experience with two
most commonly done procedures that are used for surgi-
cal treatment of the trigeminal neuralgia [5]. The other
provided comprehensive review of currently available
neurostimulation techniques that may be and are used for
the treatment of facial pain [6]. In this paper, we reviewed
our single-institution experience with the treatment of the
facial pain according to our definition of multimodality
approach.
Since our clinical practice attracts a large number of
patients with facial pain, we decided to create an algo-
rithm for its surgical treatment and summarize applicabil-
ity of such algorithm based on degree of pain relief and
patient satisfaction. The analysis presented here was
derived from a prospective study of patients with facial
pain that was approved by our Institutional Review Board
few years ago [7].
Methods
The algorithm for treatment of medically intractable facial
pain that we use is based on taking into account underly-
ing pathological processes, the anatomical distribution of
pain, pain characteristics, the patient's age and medical
condition, associated medical problems, the history of
previous surgical interventions, and, in some cases, the
results of psychological evaluation. The largest part of our
algorithmic approach to facial pain is, not surprisingly,
dedicated to treatment of trigeminal pathology, including
TN and other disorders of trigeminal system (trigeminal
neuropathy, deafferentation, etc.). Surgeries for migraine
and other headache syndromes are currently in an early
research phase; dental and TMJ problems rarely come to
neurosurgical attention but should be kept as a part of dif-
ferential diagnosis in patients with chronic facial pain;
non-trigeminal disorders (related to involvement of the
glossopharyngeal, intermediate and occipital nerves) are
significantly less common (at least in our practice) and, in
most cases, may be diagnosed by specific distribution of
pain that involves ear, throat, occiput, neck alone or in
addition to facial territory.
Importance of detection of the underlying pathological
processes may be illustrated by difference in surgical man-
agement of various possible causes of symptomatic (sec-
ondary) TN (neoplasms, vascular malformations, etc.)
that would require definitive treatment (such as tumor
resection) in order to obtain pain control [8], or sympto-
matic TN caused by demyelination (as in multiple sclero-
sis (MS)) for which destructive procedures are considered
to be a preferred treatment approach. In most cases of typ-
ical TN (TN types 1 and 2), where underlying pathology
cannot be clearly identified, neurovascular compression is
postulated to be a cause of pain (so called idiopathic TN),
non-destructive procedure – microvascular decompres-
sion (MVD) – may be considered a treatment of choice, as
this modality (a) provides the only curative solution, (b)
is not associated with sensory loss as a result of surgery, (c)
has very high success rate, and (d) is associated with the
lowest rate of pain recurrence.
Patient's age and medical condition become important in
algorithmic approach to facial pain, particularly in those
diagnosed with TN, since MVD requires craniotomy and
carries certain risk of complications related to surgery and
general anesthesia. This risk increases with the patient's
age and associated co-morbidities. Therefore, for older
and medically unfit patients, preference is given to less
invasive percutaneous destructive procedures and stereo-
tactic radiosurgery (SRS).
Although MVD has been shown effective in elderly TN
patients and those with secondary TN from MS, we do not
routinely suggest it for these patient categories. This
approach may reflect our institutional bias, but in the
authors' opinion, the lower yield of MVD in MS and
higher risk of complications in elderly patients undergo-
ing MVD do not justify considering MVD as the first
choice in these particular situations.
Among percutaneous destructive procedures that are used
for TN, each of three modalities (RF gangliolysis, glycerolHead & Face Medicine 2007, 3:30 http://www.head-face-med.com/content/3/1/30
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injection, and balloon microcompression) may be used
for idiopathic (TN types 1 and 2) and symptomatic (sec-
ondary) TN, but in our opinion, RF gangliolysis works
best in those TN patients that present with pain in 2nd or
3rd division of the trigeminal nerve (maxillary and man-
dibular nerves) due to somewhat higher risk of corneal
hypesthesia or anesthesia with resultant keratitis and cor-
neal abrasions if 1st branch (ophthalmic nerve) fibers are
targeted by RF energy.
Therefore, balloon microcompression in our algorithm is
reserved for patients with TN whose pain involves distri-
bution of the first trigeminal branch (ophthalmic nerve)
with or without other branches.
SRS with Gamma Knife (or linear accelerator) is reserved
for those patient with TN types 1 and 2 (typical and atyp-
ical TN) who prefer to avoid any mechanically invasive
procedures (open or percutaneous interventions) and
only if they can tolerate their pain for 1–3 months that are
required for pain relief after radiosurgery.
The nature of pain and results of neurological evaluation
allow one to diagnose other pain syndromes involving the
Table 2: Burchiel's classification scheme for facial pains commonly encountered in neurosurgical practice (modified from Burchiel, 
2003 [3])
Pain category History/Pain pattern Other names
Trigeminal neuralgia type 1 Spontaneous onset (>50% episodic pain) Idiopathic trigeminal neuralgia
Trigeminal neuralgia type 2 Spontaneous onset (≥50% constant pain) Atypical trigeminal neuralgia
Trigeminal neuropathic pain Trigeminal injury - unintentional (trauma, sinus 
surgery)
Trigeminal deafferentation pain Trigeminal injury – intentional deafferentation (after 
destructive procedures)
Anesthesia dolorosa/hypesthesia dolorosa
Symptomatic trigeminal neuralgia/MS Multiple sclerosis
Symptomatic trigeminal neuralgia/other causes Posterior fossa mass lesions, Chiari malformation Secondary trigeminal neuralgia
Postherpetic neuralgia Trigeminal Herpes Zoster outbreak
Atypical facial pain Somatoform pain disorder
Table 1: Common categories of facial pain
Headache
Tension headache
Migraine and equivalents
Cluster headache
Non-neurogenic pain
Sinusitis
TMJ pain
Trigeminal neuralgia
Idiopathic TN (TN type 1)
Secondary TN (symptomatic TN)
Atypical trigeminal neuralgia (TN type 2)
Trigeminal neuropathic pain
Trigeminal injury (unintentional, incidental trauma)
Postherpetic neuralgia
Anesthesia dolorosa/trigeminal deafferentation pain (intentional deafferentation)
Other cranial neuralgias and other clinical syndromes
Glossopharyngeal neuralgia
Sudden unilateral neuralgiform pain with conjunctival injection and tearing
Eagle syndrome (elongated styloid process)
Tolosa-Hunt syndrome (cavernous sinus/orbital apex inflammation)
Gradenigo syndrome (petrous apex syndrome)
Ramsay-Hunt syndrome (herpetic infection of nervus intermedius)
Raeder (paratrigeminal) syndrome
Cancer-related facial pain
Atypical facial pain (somatoform pain disorder)
The list presented here is given for purposes of illustration of the algorithm described in this article. It is by no means comprehensive and the order 
of conditions does not reflect their incidence or severity.Head & Face Medicine 2007, 3:30 http://www.head-face-med.com/content/3/1/30
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face and differentiate them from classic TN (TN type 1).
For example, presence of constant pain, lack of response
to carbamazepine, and associated numbness would put
the patient either into category of "atypical TN (ATN)" (if
sharp and shooting pain is present) or "trigeminal neuro-
pathic pain (TNP)" (where pain is predominantly con-
stant and the neurological deficit is more obvious). Both
of these conditions may be classified as TN type 2 (if the
pain is idiopathic), true TNP (if caused by unintentional
or incidental trauma) or trigeminal deafferentation pain
(if caused by previous deafferenting procedures – surger-
ies, injections, etc.) [3,4]. MVD for patients in this cate-
gory may be less effective than for those with TN type 1
(typical TN) and destructive procedures will have limited
value only (this is true about both percutaneous proce-
dures and SRS). For TN type 2 (ATN), the vascular com-
pression is thought to be more distal, but for TNP in its
broad definition (that includes neuropathic, deafferenta-
tion and post-stroke pains) the pain most likely represents
partial or complete deafferentation from previous injury
(either iatrogenic or traumatic) or cerebral infarction (tha-
lamic strokes, lateral medullary infarctions – Wallenberg
syndrome). The limited choices of intervention include
(a) peripheral nerve stimulation (PNS) [9,10] that works
particularly good in TNP patients, (b) trigeminal tractot-
omy/nucleotomy [11,12] that due to high risk of compli-
cations is reserved for patients with cancer-related pain
and those with short life-expectancy, and (c) motor cortex
stimulation (MCS) [13-15], which mechanism is not
completely understood but which applicability for facial
deafferentation pain has been repeatedly shown in multi-
ple centers all over the world, including the United States.
Atypical facial pain (AFP), on the other hand, does not
follow clear anatomical distribution, frequently crosses
midline, and, not surprisingly, almost inevitably corre-
lates with presence of psychological aberrations. Patients
with AFP do not improve with surgical interventions;
therefore, it is recommended to avoid surgery and con-
Table 3: Summary of surgical procedures for treatment of facial pain
Procedure name Surgical details Current status Notes
Microvascular decompression Retromastoid craniectomy, 
decompression of trigeminal nerve 
root from offending vessel(s)
Widely accepted (Jannetta 
procedure)
Non-destructive nature Requires 
general anesthesia Immediate 
improvement of pain
Radiofrequency gangliolysis Percutaneous needle procedure; 
thermal destruction of trigeminal 
ganglion and root
One of the most established 
options for TN
Destructive procedure Intended to 
be very selective May be done with 
sedation Requires patient 
cooperation Immediate 
improvement of pain
Glycerol gangliolysis Percutaneous needle insertion; 
chemical destruction of trigeminal 
fibers
Very commonly used 
percutaneous procedure
Destructive procedure May be 
selective No need in general 
anesthesia Immediate improvement 
of pain
Balloon compression Percutaneous needle insertion; 
mechanical destruction of trigeminal 
fibers
Commonly used percutaneous 
procedure
Destructive procedure Non-
selective May be done under general 
anesthesia Does nor require patient 
cooperation Immediate 
improvement of pain
Stereotactic radiosurgery Focused radiation aimed at the 
trigeminal nerve root
Accepted treatment option Destructive procedure Non-
selective No need in general 
anesthesia Improvement of pain may 
take several months
Neurectomy Surgical removal or interruption of 
peripheral branch of the trigeminal 
nerve
Rarely used option Destructive procedure Highly 
selective Does not require general 
anesthesia Results in complete 
numbness of the area Immediate 
improvement of pain
Peripheral nerve stimulation Electrical stimulation of the peripheral 
branch of trigeminal nerve
Relatively new application Non-destructive procedure Involves 
trial before implantation Adjustable/
reversible
Motor cortex stimulation Electrical stimulation of motor cortex 
with electrode inserted into epidural 
space through small craniotomy
Considered "off label" indication in 
the US
Non-destructive procedure 
Requires craniotomy and general 
anesthesia Adjustable/reversible
Trigeminal tractotomy Percutaneous or open surgical 
destruction of the nucleus caudalis in 
the upper spinal cord
Very rarely used treatment option Destructive procedure High risk of 
complications Immediate 
improvement of painHead & Face Medicine 2007, 3:30 http://www.head-face-med.com/content/3/1/30
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tinue treatment with anticonvulsants and antidepressants
as soon as the diagnosis is made.
Other, less frequent pain syndromes, such as GPN [16],
Eagle syndrome [17], Tolosa-Hunt, Raeder and Gradenigo
syndromes, require completely different algorithm that
also includes non-destructive and destructive options.
Description of the algorithm (Figure 1)
1. If the patient has anatomical distribution of pain, deter-
mine if this distribution correlates with trigeminal terri-
tory or territory supplied by other nerves of face/head
region (glossopharyngeal, n. intermedius, occipital); if it
is limited to trigeminal area, proceed to step #2; if other
nerves are involved, proceed with step #13; if pain is non-
anatomical in character, proceed with step #14.
2. If the patient's pain is limited to trigeminal distribution,
define if it has features of TN – sharp shooting (electric-
shock like) pain, triggerable by touch, speech, cold wind,
etc., responsive to oral carbamazepine, with spontaneous
remissions, pain-free intervals – proceed with step #3; if
any of the typical TN features are absent, but the majority
of pain is sharp and shooting in nature, proceed with step
#6; if the pain is in trigeminal distribution but is primarily
constant and is associated with certain degree of sensory
loss, proceed with step #9; obtain MRI of the brain in all
of these cases to rule out mass lesions and demyelination.
3. If the patient has TN type 1 (typical TN) – as docu-
mented by TN features and brain imaging negative for
mass lesions in the cerebellopontine angle and demyeli-
nation – the procedure of choice is microvascular decom-
pression  (MVD) through suboccipital craniotomy,
independently of the trigeminal branch involved.
4. In the situation described in #3, if the patient cannot
have MVD due to advanced age (older than 70) or severity
of medical condition, or if the patient prefers to avoid
open surgical intervention, or if the pain recurred after
MVD performed in the past, or if the brain imaging is sug-
gestive of demyelination (e.g., MS), and  if the pain
involves 3rd, 2nd or 2nd and 3rd branches, the procedure of
choice would be percutaneous stereotactic radiofrequency
gangliolysis.
5. In all situations described in #4 and if the pain involves
the 1st branch distribution alone or in any combination
with 2nd and 3rd branches, the procedure of choice is per-
cutaneous trigeminal balloon microcompression.
6. If the patient has TN with atypical features, (some
numbness, presence of constant pain in addition to sharp
shooting sensation, pain is unresponsive to car-
bamazepine), the most likely diagnosis is TN type 2, and
the algorithm from #3–5 applies, but the patient is
informed about higher chance of complications, includ-
ing facial numbness and pain recurrence.
7. If the patient's TN types 1 and 2 (typical or atypical TN)
is associated with a mass lesion of the cerebellopontine
angle, the surgery should address the mass lesion and the
pain is expected to improve once the mass lesion is elim-
inated.
8. If the patient fits description of steps #3–6 but does not
want to have any invasive intervention, the option of
choice becomes stereotactic radiosurgery with Gamma Knife
or, less often, linear accelerator; the patient is informed
about destructive nature of radiosurgery and the lag
between the treatment and onset of pain relief (1 to 6
months).
9. If the patient is diagnosed with the trigeminal neuro-
pathic pain (not neuralgia), and maintains some degree
of sensation in the area of pain, and the pain is localized
to distribution of the supraorbital or infraorbital nerves,
the treatment of choice is trigeminal branch stimulation
with peripheral nerve stimulation technique.
10. If the patient fits description of step #9 and the pain is
localized to distribution of any branches of the mandibu-
lar nerve, the treatment of choice is neurectomy or nerve
decompression or non-surgical management.
11. If the patient has constant pain and complete numb-
ness in the area of pain (anesthesia dolorosa) as a result of
previous surgical deafferentation or stroke, and  life
expectancy more than 6 months, the treatment of choice
is the contralateral motor cortex stimulation with epidural
intracranial electrodes.
12. If the patient has trigeminal deafferentation pain with
sensory impairment (anesthesia dolorosa), or any type of
cancer-related pain in the area of face, and short (less than
6 months) life expectancy, the treatment of choice is per-
cutaneous stereotactic trigeminal tractotomy.
13. If the patient's pain fits into category of other specific
facial pain syndrome, such as glossopharyngeal neuralgia,
cluster headaches, sudden unilateral neuralgiform pain
with conjunctival injection and tearing (SUNCT), Eagle,
Gradenigo, Tolosa-Hunt, Raeder, and other syndromes, a
dedicated treatment modalities are considered outside of
this algorithm.
14. If the patient is diagnosed with atypical facial pain, the
surgery is not recommended and the patient is managed by
combination of anticonvulsants and antidepressants.Head & Face Medicine 2007, 3:30 http://www.head-face-med.com/content/3/1/30
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Results
Our algorithmic approach was used in 138 consecutive
patients with medically intractable facial pain. The infor-
mation about demographics, diagnoses and initial surgi-
cal interventions for these patients is summarized in Table
4. Clinical evaluations and diagnostic workups were fol-
lowed in each case by the systematic choice of the appro-
priate intervention. The algorithm has proved easy to
follow, and the recommendations include the identifica-
tion of the optimal surgery for each patient with other
options reserved for failures or recurrences. For example,
among these patients almost two thirds (62%) had
trigeminal neuralgia, majority of which may be classified
as a TN type 1 (typical idiopathic TN), and the remaining
group was divided between the symptomatic TN (due to
neoplasms and multiple sclerosis) and TN type 2 (atypical
idiopathic TN). Only few patients had other cranial neu-
ralgias and syndromes, and the incidence of TNP and AFP
was about 10% each.
The number of MVD and RF gangliolyses was approxi-
mately the same; RF gangliolysis was done as a repeat pro-
cedure for pain recurrence in 9 cases after previous RF
ganglilolysis and in 3 cases after previous MVD. Balloon
compression was used only on five occasions and only in
patients with TN and pain involving 1st branch distribu-
tion. Relatively recent acquisition of Gamma Knife is
reflected by its relative underutilization in our practice,
but this modality is expected to be used in about 25% of
all TN patients.
PNS approach [9,10] was used only in patients with TNP
due to post-traumatic or post-surgical neuropathy
(trigeminal deafferentation pain). MCS [15] was used in
those with facial pain after thalamic infarctions and with
anesthesia dolorosa (an extreme case of trigeminal deaf-
ferentation pain developed as a complication of previous
interventions for treatment of TN). Computed tomogra-
phy (CT)-guided trigeminal tractotomy is considered only
Flow diagram of the treatment algorithm Figure 1
Flow diagram of the treatment algorithm.Head & Face Medicine 2007, 3:30 http://www.head-face-med.com/content/3/1/30
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in patients with short life expectancy and is rarely per-
formed.
Patients with atypical facial pain (AFP) were not offered
any surgical intervention, mainly on the basis of its inef-
fectiveness in suppressing AFP symptoms and risk of
unwarranted complications. The patients understood the
rationale for avoiding the surgery and proceeded with
medical treatment, usually including anticonvulsant and
antidepressant medications. In addition to this, several
other patients with different pain conditions were advised
against surgery or chose not to have operations for various
reasons.
From all patients followed for their facial pain, with the
exception of those with AFP and those that underwent
Gamma Knife SRS, 95.8% obtained pain relief upon dis-
charge from the hospital
Conclusion
The treatment algorithm for the intractable facial pain
described in this paper appears to be effective for patients
with a wide variety of painful conditions involving the
face. It applies to vast majority of patients presenting to a
neurosurgical clinic and is associated with extremely high
degree of pain relief and patient satisfaction. Therefore, in
our opinion, it may be recommended for use in other
institutions for subsequent validation and wider adop-
tion.
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trigeminal neuropathic pain.
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